+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Parainfluenza Virus Test Kits Market by Technology (Immunoassay, Molecular), Product (Isothermal Kits, Rapid Test Kits, Real Time Pcr Kits), End User, Sample Type, Application - Global Forecast 2025-2030- Product Image
Human Parainfluenza Virus Test Kits Market by Technology (Immunoassay, Molecular), Product (Isothermal Kits, Rapid Test Kits, Real Time Pcr Kits), End User, Sample Type, Application - Global Forecast 2025-2030- Product Image
New

Human Parainfluenza Virus Test Kits Market by Technology (Immunoassay, Molecular), Product (Isothermal Kits, Rapid Test Kits, Real Time Pcr Kits), End User, Sample Type, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123392
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The landscape of human parainfluenza virus test kits has become increasingly pivotal in the global healthcare framework as clinicians and laboratorians strive to address acute respiratory infections with precision and speed. Emerging epidemiological patterns underscore a pronounced need for diagnostic methodologies capable of differentiating human parainfluenza virus from other respiratory pathogens in both inpatient and outpatient settings. As a result, advances in assay performance, turnaround times, and ease of use have taken center stage, reshaping investment priorities across private and public laboratories.

Against this backdrop, our executive summary offers a concise yet comprehensive introduction to the critical factors influencing the development, adoption, and commercialization of parainfluenza virus test kits. Rapid progress in molecular amplification methods and immunoassays is converging with evolving reimbursement policies and heightened regulatory scrutiny, creating a dynamic environment that demands strategic foresight. This summary sets the stage for a deeper exploration of market dynamics, technological innovations, and regulatory landscapes, empowering decision-makers to anticipate risks and capitalize on emerging opportunities.

Charting the Transformational Shifts Reshaping the Human Parainfluenza Virus Test Kit Market in the Wake of Technological and Regulatory Evolution

Over the past several years, the human parainfluenza virus test kit market has witnessed transformative shifts driven by breakthroughs in molecular diagnostics and a paradigm shift toward point-of-care applications. No longer confined to centralized laboratories, testing is migrating closer to the patient, with portable real time PCR platforms and isothermal amplification systems enabling accurate results within minutes. This evolution addresses the demand for rapid decision support in emergency departments and rural clinics, thereby expanding diagnostic reach and improving patient outcomes.

Concurrently, immunoassay technologies have undergone a renaissance, with enhancements in chemiluminescence immunoassay and lateral flow immunoassay formats delivering higher sensitivity and specificity. These improvements have fortified the role of immunoassays in routine screening and triage workflows, while next generation sequencing tools are finding niche applications in reference laboratories for outbreak characterization and epidemiological surveillance. Altogether, these technological and workflow advancements are recalibrating competitive dynamics, as established diagnostics firms and agile start-ups vie to capture share in an increasingly fragmented ecosystem.

Assessing the Extensive Impact of Forthcoming United States Tariff Policies on the Supply Chain Dynamics of Parainfluenza Virus Test Kits

With the introduction of new tariff measures on imported laboratory equipment and reagents next year, the human parainfluenza virus test kit supply chain will experience significant pressure. Raw material costs are set to rise for many manufacturers, compelling them to reassess sourcing strategies and negotiate new agreements with domestic and international suppliers. These cost pressures may translate into higher list prices, potentially constraining procurement decisions by budget-sensitive diagnostic laboratories and public health agencies.

In addition, importers of key assay components such as enzymes, antibodies, and consumables will need to absorb or pass on additional duties, affecting profitability and competitive positioning. Some manufacturers are already evaluating alternative supply routes and seeking tariff exemptions for critical diagnostic inputs. As stakeholders navigate these headwinds, collaboration between industry, regulatory bodies, and trade authorities will be essential to maintain testing capacity and prevent disruptions that could compromise patient care and public health preparedness.

Unveiling Insightful Market Segmentation Patterns That Drive Precise Targeting and Strategic Development in Parainfluenza Virus Test Kits

Segment analysis reveals distinct pathways for growth and innovation across technology, product, end user, sample type, and application dimensions. Within the technology domain, immunoassay techniques encompass chemiluminescence immunoassay, enzyme linked immunosorbent assay, and lateral flow immunoassay, each offering unique trade-offs between throughput, automation, and ease of use, while molecular approaches including isothermal amplification, next generation sequencing, and real time PCR deliver unparalleled sensitivity and multiplexing capacity. Product segmentation highlights a clear divide between isothermal kits optimized for rapid, near-patient testing, rapid test kits designed for simplicity and speed, and real time PCR kits that balance accuracy with moderate throughput demands.

From the perspective of end users, academic and research institutes are advancing fundamental virology studies and surveillance, whereas diagnostic laboratories focus on high-volume screening and confirmatory testing. Hospitals integrate both POC and centralized solutions to streamline patient management, and point of care centers prioritize simplicity and minimal infrastructure requirements. Sample type considerations span nasopharyngeal swab, oropharyngeal swab, and sputum, each presenting distinct pre-analytical challenges that influence kit design and validation protocols. Finally, application segmentation underscores the roles of clinical diagnosis in supporting therapeutic decisions, epidemiological surveillance in tracking outbreak dynamics, and research applications that drive assay innovation and new biomarker discovery.

Analyzing Regional Variations and Growth Drivers That Shape the Global Demand Landscape for Parainfluenza Virus Test Kits

Geographic diversity in healthcare infrastructure, regulatory frameworks, and reimbursement dynamics has a profound effect on the adoption of parainfluenza virus test kits. In the Americas, robust public health networks and significant investments in molecular diagnostics foster a fertile environment for real time PCR and next generation sequencing solutions, especially in metropolitan centers where rapid outbreak response is critical. Meanwhile, diagnostic laboratories in Europe, the Middle East & Africa demonstrate growing interest in multiplexed immunoassay platforms that offer cost efficiencies and streamlined workflows amidst budgetary constraints.

In the Asia-Pacific region, rising healthcare expenditures, expanding point of care networks, and supportive government initiatives to strengthen infectious disease surveillance drive uptake of both rapid test kits and isothermal amplification technologies. Rural clinics across emerging markets are increasingly deploying portable, user-friendly devices to decentralize testing, while urban hospitals integrate advanced POC platforms to reduce turnaround times and improve patient throughput. Together, these regional insights illuminate the strategic imperatives for market entrants seeking to tailor product portfolios and support frameworks to localized needs.

Identifying the Pioneering Companies Driving Innovation and Competitive Differentiation in the Parainfluenza Virus Test Kit Market Landscape

Leading diagnostics firms are engaging in strategic partnerships, product line expansions, and platform integrations to maintain competitive differentiation in this evolving market. Established multinational corporations leverage global distribution networks to introduce high-throughput real time PCR solutions and next generation sequencing applications, while regional players focus on rapid test kits and isothermal amplification systems optimized for local conditions. Several companies have also invested in proprietary chemiluminescence immunoassay reagents to strengthen their presence in centralized laboratory workflows.

Collaboration between instrument manufacturers and reagent specialists is accelerating the development of cartridge-based assays that simplify user experience and reduce contamination risk. Companies are enhancing software capabilities to provide integrated data management and connectivity solutions, aligning diagnostics with broader digital health initiatives. Additionally, targeted acquisitions of niche technology providers are expanding portfolios to address multiplexed respiratory panels, positioning companies to capture emerging demand for comprehensive pathogen profiling.

Strategic and Actionable Recommendations to Propel Leadership Success in the Developing Human Parainfluenza Virus Test Kit Industry Environment

Industry leaders should proactively diversify sourcing strategies to mitigate the impact of impending tariff increases, including exploring local manufacturing partnerships and alternative supply routes for critical reagents. Concurrently, investment in modular platform designs that can accommodate both immunoassay and molecular assays will enhance flexibility and protect against technology-specific disruptions. It is also imperative to develop tiered product portfolios that align with the distinct needs of high-throughput laboratories, decentralized point of care sites, and resource-limited settings.

Strengthening collaborations with clinical research networks and public health agencies will facilitate real-world validation studies and accelerate regulatory approvals. Moreover, integrating advanced data analytics and connectivity features into test kits can unlock value by supporting real-time surveillance and predictive modeling. By adopting a holistic approach that aligns product innovation, supply chain resilience, and strategic partnerships, industry leaders can secure sustainable growth and reinforce their role as trusted diagnostic solution providers.

Detailing Comprehensive Research Methodology Approaches Ensuring Robustness and Reliability of Human Parainfluenza Virus Test Kit Market Analysis

This analysis draws upon a multi-tiered research methodology that integrates primary interviews with key opinion leaders, executives, and laboratory directors, supplemented by comprehensive secondary research. Data triangulation ensures consistency across industry reports, regulatory filings, company disclosures, and peer-reviewed literature. Qualitative insights from structured discussions with technical experts provide context for emerging assay performance benchmarks and workflow requirements, while quantitative data is validated through cross-referencing of publicly available procurement statistics and financial disclosures.

Segmentation parameters, including technology, product type, end user, sample type, and application, were rigorously defined to reflect the diverse market structure. Geographic analyses incorporate both macroeconomic indicators and localized healthcare spending trends. Limitations and assumptions are transparently documented, with sensitivity analyses conducted to test the robustness of key findings. This methodological rigor underpins the reliability of the conclusions and recommendations presented herein.

Summarizing Key Findings and Strategic Implications That Define the Future Trajectory of the Human Parainfluenza Virus Test Kit Market Landscape

In summary, the human parainfluenza virus test kit market stands at the intersection of technological progress, regulatory evolution, and shifting clinical imperatives. Reagent developers and instrument manufacturers are driving innovation across both immunoassay and molecular domains, while new tariff measures will reshape supply chain considerations and cost structures. Understanding nuanced segmentation across product types, end users, sample matrices, and applications will be critical for precise market positioning.

Regional variations underscore the importance of tailored strategies that address the distinct needs of the Americas, Europe, the Middle East & Africa, and Asia-Pacific markets. Leading companies are forging strategic alliances, expanding product portfolios, and integrating digital connectivity to maintain differentiation. By aligning investments in platform flexibility, supply chain resilience, and data-driven surveillance, stakeholders can navigate the evolving landscape and capitalize on opportunities to enhance patient care and public health preparedness.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Immunoassay
      • Chemiluminescence Immunoassay
      • Enzyme Linked Immunosorbent Assay
      • Lateral Flow Immunoassay
    • Molecular
      • Isothermal Amplification
      • Next Generation Sequencing
      • Real Time Pcr
  • Product
    • Isothermal Kits
    • Rapid Test Kits
    • Real Time Pcr Kits
  • End User
    • Academic And Research Institutes
    • Diagnostic Laboratories
    • Hospitals
    • Point Of Care Centers
  • Sample Type
    • Nasopharyngeal Swab
    • Oropharyngeal Swab
    • Sputum
  • Application
    • Clinical Diagnosis
    • Epidemiological Surveillance
    • Research
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • bioMérieux SA
  • QIAGEN N.V.
  • Hologic Inc.
  • Seegene Inc.
  • Luminex Corporation
  • Becton, Dickinson and Company
  • GenMark Diagnostics, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of high-throughput multiplex molecular assays for parainfluenza virus detection in pediatric hospital settings
5.2. Integration of portable point-of-care isothermal amplification devices enabling rapid parainfluenza virus testing in outpatient clinics
5.3. Emergence of digital microfluidic platforms for simultaneous parainfluenza subtyping and antiviral resistance profiling at the point of care
5.4. Adoption of telemedicine-linked self-collection sampling kits for community-based surveillance of human parainfluenza infections
5.5. Strategic collaborations between diagnostic manufacturers and artificial intelligence developers for automated parainfluenza assay interpretation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Parainfluenza Virus Test Kits Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. Chemiluminescence Immunoassay
8.2.2. Enzyme Linked Immunosorbent Assay
8.2.3. Lateral Flow Immunoassay
8.3. Molecular
8.3.1. Isothermal Amplification
8.3.2. Next Generation Sequencing
8.3.3. Real Time Pcr
9. Human Parainfluenza Virus Test Kits Market, by Product
9.1. Introduction
9.2. Isothermal Kits
9.3. Rapid Test Kits
9.4. Real Time Pcr Kits
10. Human Parainfluenza Virus Test Kits Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Point of Care Centers
11. Human Parainfluenza Virus Test Kits Market, by Sample Type
11.1. Introduction
11.2. Nasopharyngeal Swab
11.3. Oropharyngeal Swab
11.4. Sputum
12. Human Parainfluenza Virus Test Kits Market, by Application
12.1. Introduction
12.2. Clinical Diagnosis
12.3. Epidemiological Surveillance
12.4. Research
13. Americas Human Parainfluenza Virus Test Kits Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Parainfluenza Virus Test Kits Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Parainfluenza Virus Test Kits Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Holding AG
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Abbott Laboratories
16.3.4. BioMérieux SA
16.3.5. QIAGEN N.V.
16.3.6. Hologic Inc.
16.3.7. Seegene Inc.
16.3.8. Luminex Corporation
16.3.9. Becton, Dickinson and Company
16.3.10. GenMark Diagnostics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET: RESEARCHAI
FIGURE 26. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 100. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 101. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 102. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 103. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 104. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 114. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 116. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 117. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 118. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 186. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 187. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 188. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 189. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 200. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 201. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 202. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 203. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 204. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 205. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 228. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 229. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 230. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 231. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 232. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 233. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 242. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 243. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 244. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 245. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 246. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 247. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. DENMARK HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Parainfluenza Virus Test Kits market report include:
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • bioMérieux SA
  • QIAGEN N.V.
  • Hologic Inc.
  • Seegene Inc.
  • Luminex Corporation
  • Becton, Dickinson and Company
  • GenMark Diagnostics, Inc.

Related Topics

Related Reports

Respiratory Syncytial Virus (RSV) Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Respiratory Syncytial Virus (RSV) Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Greene's Infectious Diseases of the Dog and Cat. Edition No. 5 - Product Image

Greene's Infectious Diseases of the Dog and Cat. Edition No. 5

  • Book
Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2-Volume Set. Edition No. 9 - Product Image

Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2-Volume Set. Edition No. 9

  • Book
Diagnostic Pathology: Infectious Diseases. Edition No. 3 - Product Image

Diagnostic Pathology: Infectious Diseases. Edition No. 3

  • Book
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032 - Product Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032

  • Report
  • 221 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.